These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33579840)

  • 21. Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.
    Tanprasertsuk J; Johnson EJ; Johnson MA; Poon LW; Nelson PT; Davey A; Martin P; Barbey AK; Barger K; Wang XD; Scott TM
    J Alzheimers Dis; 2019; 70(1):35-49. PubMed ID: 31177211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmortem neurodegenerative markers and trajectories of decline in cognitive systems.
    Wilson RS; Yang J; Yu L; Leurgans SE; Capuano AW; Schneider JA; Bennett DA; Boyle PA
    Neurology; 2019 Feb; 92(8):e831-e840. PubMed ID: 30674595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Neurofibrillary Tangle Distribution With Age at Onset-Related Clinical Heterogeneity in Alzheimer Disease: An Autopsy Study.
    Smirnov DS; Salmon DP; Galasko D; Goodwill VS; Hansen LA; Zhao Y; Edland SD; Léger GC; Peavy GM; Jacobs DM; Rissman R; Pizzo DP; Hiniker A
    Neurology; 2022 Feb; 98(5):e506-e517. PubMed ID: 34810247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Greater Variability in Cognitive Decline in Lewy Body Dementia Compared to Alzheimer's Disease.
    Giil LM; Aarsland D
    J Alzheimers Dis; 2020; 73(4):1321-1330. PubMed ID: 31903991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal course of neurodegenerative effects on cognition in old age.
    Wilson RS; Capuano AW; Bennett DA; Schneider JA; Boyle PA
    Neuropsychology; 2016 Jul; 30(5):591-9. PubMed ID: 27111293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of transactive response DNA binding protein 43 with nuclear factor κB in mild cognitive impairment with episodic memory deficits.
    Ohta Y; Tremblay C; Schneider JA; Bennett DA; Calon F; Julien JP
    Acta Neuropathol Commun; 2014 Apr; 2():37. PubMed ID: 24690380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.
    Robinson JL; Molina-Porcel L; Corrada MM; Raible K; Lee EB; Lee VM; Kawas CH; Trojanowski JQ
    Brain; 2014 Sep; 137(Pt 9):2578-87. PubMed ID: 25012223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Grey matter ageing-related tau astrogliopathy: associations with brain pathologies and cognitive decline.
    Agrawal S; Yu L; Leurgans SE; Kapasi A; Barnes LL; Bennett DA; Boyle PA; Schneider JA
    Brain; 2024 Oct; 147(10):3501-3512. PubMed ID: 39045644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal course and pathologic basis of unawareness of memory loss in dementia.
    Wilson RS; Boyle PA; Yu L; Barnes LL; Sytsma J; Buchman AS; Bennett DA; Schneider JA
    Neurology; 2015 Sep; 85(11):984-91. PubMed ID: 26311746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD.
    Nag S; Yu L; Wilson RS; Chen EY; Bennett DA; Schneider JA
    Neurology; 2017 Feb; 88(7):653-660. PubMed ID: 28087828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.
    Grober E; Qi Q; Kuo L; Hassenstab J; Perrin RJ; Lipton RB
    J Alzheimers Dis; 2021; 80(1):185-195. PubMed ID: 33492286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
    Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
    J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
    Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ
    Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease.
    Uemura MT; Robinson JL; Cousins KAQ; Tropea TF; Kargilis DC; McBride JD; Suh E; Xie SX; Xu Y; Porta S; Uemura N; Van Deerlin VM; Wolk DA; Irwin DJ; Brunden KR; Lee VM; Lee EB; Trojanowski JQ
    Acta Neuropathol; 2022 Jan; 143(1):15-31. PubMed ID: 34854996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Delirium With Cognitive Decline in Late Life: A Neuropathologic Study of 3 Population-Based Cohort Studies.
    Davis DH; Muniz-Terrera G; Keage HA; Stephan BC; Fleming J; Ince PG; Matthews FE; Cunningham C; Ely EW; MacLullich AM; Brayne C;
    JAMA Psychiatry; 2017 Mar; 74(3):244-251. PubMed ID: 28114436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults.
    Dang C; Harrington KD; Lim YY; Ames D; Hassenstab J; Laws SM; Yassi N; Hickey M; Rainey-Smith SR; Robertson J; Rowe CC; Sohrabi HR; Salvado O; Weinborn M; Villemagne VL; Masters CL; Maruff P;
    Arch Clin Neuropsychol; 2019 Jul; 34(5):585-598. PubMed ID: 30272115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.
    Kraybill ML; Larson EB; Tsuang DW; Teri L; McCormick WC; Bowen JD; Kukull WA; Leverenz JB; Cherrier MM
    Neurology; 2005 Jun; 64(12):2069-73. PubMed ID: 15985574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline.
    Yu L; Boyle PA; Leurgans S; Schneider JA; Bennett DA
    Neurobiol Aging; 2014 Apr; 35(4):819-26. PubMed ID: 24199961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.